Physician

Hematology

Dr. David F. Trent, MD

David Trent works in the field of Hematology. He graduated from Virginia Commonwealth University School of Medicine. David Trent is also a published MD. He has 2 publication published. The most recent publication is: Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium. David Trent is registered with Medicare and accepts Medicare payments.

Publications

Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung Cancer (NSCLC).

Schools

Virginia Commonwealth University School Of Medicine
Medical College Of Virginia
VCU Medical Center

Procedures Preformed

Plasmapheresis
Thoracentesis

Conditions Treated

Acute Leukemia
Adrenal Gland Cancer
Anal and Rectal Cancer
Anemia
View All

Doctors Specialties

Oncology
Hematology

Accepted Insurances

Education

Virginia Commonwealth University Health System
Virginia Commonwealth University School of Medicine

Drug Facts

NPI NUMBER		1043274251
NPPES Provider LastName		TRENT
NPPES Provider FirstName		DAVID
NPPES Provider ZIPCode		232301714
NPPES Provider State		VA
Specialty Description		Hematology/Oncology
Total Claim Count		895.0
Distinct Opioid Count		5.0
Opioid Claim Count		115.0
Percent Opioid Claims		12.85

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1043274251
Last Name Of The Provider	TRENT
First Name Of The Provider	DAVID
View All

Similar Doctors

	Dr. Khalid Matin, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Steven Grant, MD
	Dr. Haeseong S. Park, MD
	Dr. Priya Gopie, MD
	Dr. Omar A. Castaneda, MD
	Dr. Adnan Siddiqui, MD